Interleukin-2 and interleukin-6 as markers of non-response in patients with chronic hepatitis C treated with Peg-interferon α-2b [alpha-2b] and ribavirin

Ähnliche Einträge

• Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2
  von: Becker, Jürgen C., et al.
  Veröffentlicht: (2002)
• Addition of dacarbazine or cisplatin to interferon-α/interleukin-2 in metastatic melanoma: toxicity and immunological effects
  von: Keilholz, Ulrich, et al.
  Veröffentlicht: (1995)
• Immunotherapy of metastatic melanoma with interferon-α and interleukin-2: Pattern of progression in responders and patients with stable disease with or without resection of residual lesions
  von: Keilholz, Ulrich, et al.
  Veröffentlicht: (1994)
• Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks
  von: Sarrazin, Christoph, et al.
  Veröffentlicht: (2011)
• Chronic hepatitis B virus infection and interferon-α
  von: Goeser, Tobias
  Veröffentlicht: (1995)